Drug
Hlx109
Hlx109: highest development phase Phase 1, developed by Shanghai Henlius Biotech. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Shanghai Henlius Biotech
Trials
| Drug | Phase | Indication |
|---|---|---|
| HLX109 NCT07935941 | Phase 1 | First in Man Study to Evaluate Initial Safety |
Latest
No recent events.
Follow Hlx109 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.